Ivan Hyep
Patrimonio netto: 4 M $ in data 30/06/2026
Patrimonio netto: 4 M $ in data 30/06/2026
Ivan Hyep is currently Chief Financial Officer & Treasurer at Bicara Therapeutics, Inc. since 2024.
Formerly, Mr. Hyep was Finance Director at MOMA Therapeutics, Inc. from 2019 to 2021 and Finance Manager at Bain Capital LP from 2006 to 2016.
Education includes an undergraduate degree from Bentley University and an MBA from Questrom School of Business.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 08/07/2026 | 129.855 ( 0,2% ) | 4 M $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| BICARA THERAPEUTICS INC. | Direttore Finanziario/CFO | 01/03/2021 |
| Società | Posizione | Fine |
|---|---|---|
MOMA Therapeutics, Inc.
MOMA Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for regenerative medicine employing injectable gel-based scaffolds | Direttore Finanziario/CFO | 01/03/2021 |
Bain Capital LP
Bain Capital LP Financial ConglomeratesFinance Provides investment services | Corporate Officer/Principal | 10/01/2016 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 5 |
|---|---|
Bain Capital LP
Bain Capital LP Financial ConglomeratesFinance Provides investment services | Finance |
Bentley University
Bentley University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Questrom School of Business
Questrom School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MOMA Therapeutics, Inc.
MOMA Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for regenerative medicine employing injectable gel-based scaffolds | Health Technology |
Bicara Therapeutics, Inc.
Bicara Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops and sells therapeutics for tumors | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale